Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Customer [Domain] Customer [Domain] Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Accrued compensation expenses Employee-related Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization HalioDx Inc. HalioDx Inc. [Member] HalioDx Inc. Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Additional paid-in capital Additional Paid in Capital, Common Stock Right-of-use assets, financing lease Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease, Right-Of-Use Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease, Right-Of-Use Asset Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Provision of data Biopharmaceutical And Other - Provision of Data [Member] Biopharmaceutical And Other - Provision of Data Other assets Other Assets, Noncurrent Shares available for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Entity File Number Entity File Number Schedule of Other Income (Loss), net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Measurement period adjustments, increase to goodwill Goodwill, Purchase Accounting Adjustments Deferred tax liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Organization, Consolidation and Presentation of Financial Statements [Abstract] Intangible asset amortization Amortization of Intangible Assets Discount rate Operating Lease, Weighted Average Discount Rate, Percent Shares of common stock subject to outstanding options (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount HalioDx customer relationships HalioDx Customer Relationships [Member] HalioDx Customer Relationships Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Credit Facility [Domain] Credit Facility [Domain] Assets Assets [Abstract] Silicon Valley Bank Silicon Valley Bank [Member] Represents Silicon Valley Bank. Concentration risk Concentration Risk, Percentage Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021 Preferred Stock, Value, Issued Options issued and outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Term of lease Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] HalioDx HalioDx [Member] HalioDx SAS Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Related Party [Axis] Related Party [Axis] LymphMark product technology LymphMark Product Technology [Member] Represents LymphMark product technology. Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Secured Debt Secured Debt [Member] Accounts receivable Increase (Decrease) in Accounts Receivable Purchases of property and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid Supplies inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Stock-based compensation expense (non-employee) Adjustments To Additional Paid In Capital Share Based Compensation Non Employee Amount of increase In additional paid-in capital (APIC) resulting from non-employee stock-based compensation expense. Commitments and Contingencies Disclosure [Abstract] Periodic payment terms, balloon payment to be paid Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital Share Based Compensation Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Deferred revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Number of operating segments Number of Operating Segments Net loss per common share, basic (in USD per share) Earnings Per Share, Basic Current portion of acquisition-related contingent consideration Short term contingent considerations Business Combination, Contingent Consideration, Liability, Current Operating lease expense Operating Lease, Expense Dr. Tina S. Nova, Ph.D. Dr. Tina S. Nova, Ph.D. [Member] Dr. Tina S. Nova, Ph.D. 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Net identifiable assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Schedule of Revenue Disaggregation of Revenue [Table Text Block] Finite-lived intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Tax portion of vested restricted stock units Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Considerations paid in acquisition Cash paid in acquisition Business Combination, Consideration Transferred Long-term debt balance outstanding Total debt obligation Long-term Debt Finance right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Income Tax Disclosure [Abstract] Entity Small Business Entity Small Business Contract manufacturing Biopharmaceutical And Other - Contract Manufacturing [Member] Biopharmaceutical And Other - Contract Manufacturing Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Total liabilities and stockholders’ equity Liabilities and Equity Accrued other Other Accrued Liabilities, Current Term Loan Advance Term Loan Advance [Member] Represents term loan advance. Other Income and Expenses [Abstract] Current portion of deferred revenue Contract with Customer, Liability, Current Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Restricted cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] HalioDx customer backlog HalioDx Customer Backlog [Member] HalioDx Customer Backlog Proceeds from the issuance of common stock in a public offering, net of issuance costs Proceeds from Issuance Initial Public Offering Accounts payable Increase (Decrease) in Accounts Payable HalioDx SAS HalioDx SAS [Member] HalioDx SAS Operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net Loss Per Common Share Earnings Per Share [Text Block] Operating expenses: Operating Expenses [Abstract] French research tax credits Other Nonoperating Income (Expense), Foreign Tax Credit Foreign Tax Credit, Nonoperating Entity Interactive Data Current Entity Interactive Data Current 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Minimum Minimum [Member] Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Decipher product technology Decipher BioSciences Product Technology [Member] Decipher BioSciences Product Technology Entity Address, State or Province Entity Address, State or Province Equity interest acquired Business Acquisition, Percentage of Voting Interests Acquired Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Current liabilities: Liabilities, Current [Abstract] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Restricted cash Restricted cash Long term deposit Restricted Cash and Cash Equivalents, Noncurrent General and administrative General and Administrative Expense Acquisition of Decipher Biosciences, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Debt Debt Disclosure [Text Block] Financing lease liability, net of current portion Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Financing Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Financing Lease Liability Balance at beginning of period (in shares) Balance at end of period (in shares) Shares, Outstanding Line of credit Line of Credit [Member] nCounter Dx license nCounter Dx License [Member] nCounter Dx License [Member] Interest on end-of-term debt obligation Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Present value of future lease payments Operating Lease, Liability Loss on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Document Transition Report Document Transition Report Effect of foreign currency on operations Foreign Currency Transaction Gain (Loss), before Tax Common stock, $0.001 par value; 125,000,000 shares authorized, 71,432,875 and 71,123,108 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Customer concentration risk Customer Concentration Risk [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Commitments and contingencies Commitments and Contingencies Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Prosigna customer relationships Prosigna Customer Relationships [Member] Represents Prosigna customer relationships. Entity Emerging Growth Company Entity Emerging Growth Company Right-of-use assets, operating lease Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Right-Of-Use Asset Remainder of 2022 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Business Combinations Business Combination Disclosure [Text Block] Components of Other Income (Loss) Other Nonoperating Income and Expense [Text Block] Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Cover [Abstract] Cover [Abstract] Total operating expenses Costs and Expenses Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Medicare Medicare [Member] Represents Medicare. Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Financial Instrument [Axis] Financial Instrument [Axis] Shares transferred in acquisition (in shares) Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Total revenue Revenue Revenue from Contract with Customer, Excluding Assessed Tax Issuance of common stock on exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Dr. Robert S. Epstein, M.D., M.S. Dr. Robert S. Epstein, M.D., M.S. [Member] Dr. Robert S. Epstein, M.D., M.S. Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Equity [Abstract] Document Quarterly Report Document Quarterly Report Measurement Input Type [Domain] Measurement Input Type [Domain] Common Stock Common Stock [Member] Variable Rate [Axis] Variable Rate [Axis] Loss from operations Loss from operations Operating Income (Loss) Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Stock-based compensation Share-based Payment Arrangement, Noncash Expense Variable Rate [Domain] Variable Rate [Domain] Additional Paid-in Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Payments to board of directors members Related Party Transaction, Amounts of Transaction Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Accrued liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities Other income (loss), net Other income (loss), net Other Nonoperating Income (Expense) Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Sale of common stock in a public offering, net of offering costs (in shares) Stock Issued And Sold During Period, Shares, In Private Placement Number of shares issued and sold during the period in a private placement. Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Current portion of other liabilities Other Liabilities, Current Business Combinations [Abstract] Maximum Maximum [Member] Total liabilities Liabilities End-of-term debt obligation Debt Instrument, End Of Term Payment, Interest Amount Debt Instrument, End Of Term Payment, Interest Amount Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Award Type [Axis] Award Type [Axis] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Measurement Input Type [Axis] Measurement Input Type [Axis] Total stockholders’ equity Balance at beginning of period Balance at end of period Stockholders' Equity Attributable to Parent Balance Sheet Related Disclosures [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued City Area Code City Area Code Indefinite-lived intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Prepaids and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Annual rent Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Entity Address, City or Town Entity Address, City or Town Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Contingent consideration, changes in fair value Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Debt principal Debt Instrument, Face Amount Milestones Biopharmaceutical And Other - Milestones [Member] Biopharmaceutical And Other - Milestones Total purchase price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Accumulated deficit Retained Earnings (Accumulated Deficit) Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Restricted stock units Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Schedule of Fair Values of Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Issuance of common stock under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Filer Category Entity Filer Category Finance lease liabilities Finance Lease, Liability Business Acquisition [Line Items] Business Acquisition [Line Items] Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Indefinite-lived intangible assets Indefinite-lived Intangible Assets (Excluding Goodwill) Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Income tax benefit Income Tax Expense (Benefit) Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Equity Components [Axis] Equity Components [Axis] Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Accounts receivable Accounts Receivable [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Supplies and inventory Inventory, Net Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Time deposits Other Assets, Fair Value Disclosure Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Security deposit Security Deposit Current portion of long-term debt Long-term Debt, Current Maturities Product and Service [Axis] Product and Service [Axis] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Off-Market Favorable Lease Off-Market Favorable Lease [Member] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Revenue Revenue Benchmark [Member] Equity Component [Domain] Equity Component [Domain] Selling and marketing Selling and Marketing Expense 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Change in currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Value of shares transferred in acquisition Value of shares issued in acquisition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Statement [Line Items] Statement [Line Items] Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Debt Disclosure [Abstract] Weighted Average Weighted Average [Member] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Type of Adoption [Domain] Accounting Standards Update [Domain] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Schedule of Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Deferred revenue, net of current portion Contract with Customer, Liability, Noncurrent Weighted Average Amortization Period (Years) Finite-Lived Intangible Asset, Useful Life Customer [Axis] Customer [Axis] Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Title of 12(b) Security Title of 12(b) Security Total assets Assets HalioDx developed technology HalioDX Developed Technology [Member] HalioDX Developed Technology Common stock, shares authorized (in shares) Common Stock, Shares Authorized Operating lease liability, net of current portion Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Operating Lease Liability Interest paid on debt Interest Paid, Excluding Capitalized Interest, Operating Activities Document Type Document Type Research and development Research and Development Expense Product and Service [Domain] Product and Service [Domain] Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability Revolving Credit Facility Revolving Credit Facility [Member] Shares of common stock subject to outstanding options Employee And Non Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Schedule of Net Debt Obligation Schedule of Debt [Table Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Lease Contractual Term [Domain] Lease Contractual Term [Domain] Shares used to compute net loss per common share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Net loss per common share, diluted (in USD per share) Earnings Per Share, Diluted Product revenue Product [Member] Total identifiable assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Headquarters And Laboratory Facilities South San Francisco and San Diego, California, Austin, Texas, Marseille, France and Richmond, Virginia Headquarters And Laboratory Facilities South San Francisco And San Diego, California, Austin, Texas, Marseille, France And Richmond, Virginia [Member] Headquarters And Laboratory Facilities South San Francisco And San Diego, California, Austin, Texas, Marseille, France And Richmond, Virginia Headquarters And Laboratory Facilities South San Francisco Headquarters And Laboratory Facilities South San Francisco [Member] Headquarters And Laboratory Facilities South San Francisco Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Cost of revenue Cost of Revenue Deferred revenue Contract with Customer, Liability Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Other comprehensive loss: Other Comprehensive Income (Loss), Net of Tax [Abstract] Deferred tax liabilities Deferred Income Tax Liabilities, Net Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property and equipment, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Fair Value Measurements Fair Value Disclosures [Text Block] Accounts payable Accounts Payable, Current Concentration Risk Type [Axis] Concentration Risk Type [Axis] Debt Payment Tranche [Domain] Debt Payment Tranche [Domain] [Domain] for Debt Payment Tranche [Axis] Depreciation and amortization Depreciation, Depletion and Amortization Debt prepayment tranche three Debt Prepayment Tranche Three [Member] Debt Prepayment Tranche Three [Member] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] 2022 remainder of year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Supplies and inventory Increase (Decrease) in Inventories Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Financial Instruments [Domain] Financial Instruments [Domain] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Revenue: Revenues [Abstract] ASU 2014-09 Accounting Standards Update 2014-09 [Member] Document Period End Date Document Period End Date Lease Contractual Term [Axis] Lease Contractual Term [Axis] Entity Central Index Key Entity Central Index Key Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets Outstanding shares of common stock equivalents that have been excluded from diluted net loss per common share Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Sale of common stock in a public offering, net of offering costs Stock Issued And Sold During Period Value In Private Placement Value of shares issued and sold during the period in a private placement. Investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Decipher Biosciences Decipher Biosciences [Member] Decipher Biosciences Acquisition Long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Other liabilities Other Liabilities, Noncurrent Pension obligation Defined Benefit Plan, Benefit Obligation Lender Name [Axis] Lender Name [Axis] Schedule of Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Additional cash to be paid Business Combination, Contingent Consideration, Cash To Be Paid Business Combination, Contingent Consideration, Cash To Be Paid Payment of long-term debt Repayments of long-term debt Repayments of Long-term Debt Trading Symbol Trading Symbol Earnings Per Share [Abstract] Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital Share Based Compensation ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Decipher trade names Decipher Biosciences Trade Names [Member] Decipher Biosciences Trade Names Bank Time Deposits Bank Time Deposits [Member] Line of Credit Facility [Table] Line of Credit Facility [Table] Lab supplies and reagents consumed Inventory, Finished Goods, Gross Defined Benefit Plan, Type [Extensible List] Defined Benefit Plan, Type [Extensible Enumeration] Incurred liabilities in acquisition Business Combination, Consideration Transferred, Liabilities Incurred Entity Current Reporting Status Entity Current Reporting Status Current portion of operating lease liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Operating Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Operating Lease Liability Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Discount rate Measurement Input, Discount Rate [Member] NanoString NanoString [Member] Represents NanoString. Development services Biopharmaceutical And Other - Development Services [Member] Biopharmaceutical And Other - Development Services Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Statement of Comprehensive Income [Abstract] Current assets: Assets, Current [Abstract] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Entity Address, Postal Zip Code Entity Address, Postal Zip Code Equity Interest Type [Axis] Equity Interest Type [Axis] Testing revenue Testing [Member] Represents testing. Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Shares used to compute net loss per common share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Income Taxes Income Tax Disclosure [Text Block] Termination fee on loan, percentage of revolving line of credit Debt Instrument, Early Termination Fee, Percentage Debt Face Amount Debt Instrument, Early Termination Fee, Percentage Debt Face Amount Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Related Party [Domain] Related Party [Domain] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Schedule of Outstanding Common Stock Equivalents Excluded From Diluted Net Loss Per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Facilities in Marseille, France Facilities In Marseille, France [Member] Facilities In Marseille, France Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Class of Stock [Line Items] Class of Stock [Line Items] Credit Facility [Axis] Credit Facility [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Raw materials and finished diagnostic kits Inventory, Work in Process and Raw Materials Entity Address, Address Line One Entity Address, Address Line One Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Entity Address, Address Line Two Entity Address, Address Line Two Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Issuance of common stock under ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Entity Shell Company Entity Shell Company Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Total current liabilities Liabilities, Current Employee stock purchase plan Employee Stock [Member] Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-based Payment Arrangement Prepayment premium Debt Instrument, Prepayment Premium The amount of prepayment premium under the debt instrument. Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Money Market Funds Money Market Funds [Member] Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Current Fiscal Year End Date Current Fiscal Year End Date Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Operating Leases Operating Leased Assets [Line Items] Statement [Table] Statement [Table] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Current portion of financing lease liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Financing Lease Liability Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Current Financing Lease Liability Other assets Increase (Decrease) in Other Noncurrent Assets Debt Prepayment Tranche [Axis] Debt Prepayment Tranche [Axis] Debt Prepayment Tranche [Axis] Statistical Measurement [Axis] Statistical Measurement [Axis] Finance Lease, Liability, Statement of Financial Position [Extensible List] Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Total Finite-Lived Intangible Assets, Net Goodwill Goodwill Goodwill Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Offsetting [Abstract] Contract testing Biopharmaceutical And Other - Contract Testing [Member] Biopharmaceutical And Other - Contract Testing Pension Liability Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block] Early termination fee on loan Debt Instrument, Early Termination Fee Debt Instrument, Early Termination Fee Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Prosigna product technology Developed Product Technology [Member] Developed Product Technology UnitedHealthcare United Healthcare [Member] Represents United Healthcare. Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Benefit from income taxes Deferred Income Tax Expense (Benefit) Pension Plan [Member]